ETFs AstraZeneca PLC

AZN

GB0009895292

Name	Weight	AuM	1st Jan change
SYGNIA ITRIX FTSE 100 ETF	8.29%	57 M€	+12.69%	-
XACT NORDEN (UCITS ETF) - SEK	5.39%	200 M€	-1.07%	-
NOMURA NEXT FUNDS INTERNATIONAL EQUITY MSCI-KOKUSAI (YEN-HEDGED) ETF - JPY	5.17%	21 M€	+0.03%	-
XACT OMXS30 ESG UCITS ETF - SEK	4.89%	1,138 M€	+0.29%	-
XACT SVERIGE UCITS ETF - SEK	3.47%	240 M€	-4.15%	-
UBS (IRL) ETF PLC MSCI EUROPE ESG UNIVERSAL LOW CARBON SELECT UCITS ETF - ACC - EUR	2.57%	0 M€	-.--%	-
FIRST TRUST INTERNATIONAL CAPITAL STRENGTH ETF - CAD	2.53%	7 M€	+14.74%	-
XACT NORDIC HIGH DIVIDEND LOW VOLATILITY UCITS ETF - SEK	2.53%	806 M€	+6.75%	-
DEMOCRACY INTERNATIONAL FUND ETF - USD	0.97%	9 M€	+13.46%	-
DAY HAGAN/NED DAVIS RESEARCH SMART SECTOR INTERNATIONAL ETF - USD	0.89%	32 M€	+12.86%	-
VANGUARD INTERNATIONAL EQUITY INDEX FUNDS - VANGUARD FTSE ALL-WORLD EX-US ETF	0.86%	33,076 M€	+10.80%	-
LYXOR NET ZERO 2050 S&P WORLD CLIMATE PAB (DR) UCITS ETF - ACC - USD	0.57%	0 M€	-.--%	-
AMUNDI MSCI WORLD CLIMATE PARIS ALIGNED PAB UCITS ETF DR (C) - USD	0.54%	0 M€	-.--%	-
AMUNDI MSCI WORLD CLIMATE TRANSITION CTB - UCITS ETF DR (C) - USD	0.51%	0 M€	-.--%	-
LYXOR MSCI WORLD CLIMATE CHANGE (DR) UCITS ETF - ACC - USD	0.5%	0 M€	-.--%	-
VANECK SUSTAINABLE WORLD EQUAL WEIGHT UCITS ETF - EUR	0.48%	898 M€	-0.03%	-
NOMURA NEXT FUNDS INTERNATIONAL EQUITY MSCI-KOKUSAI (UNHEDGED) ETF - JPY	0.43%	331 M€	-5.77%	-
AMUNDI INDEX MSCI WORLD - UCITS ETF DR (C) - EUR	0.38%	0 M€	-.--%	-
AMUNDI INDEX MSCI WORLD UCITS ETF DR (D) - EUR	0.38%	0 M€	-.--%	-

AstraZeneca PLC is one of the world's leading pharmaceutical groups. Net sales break down by source of income as follows: - product sales (94.2%). Net sales break down by treatment area between oncology (39.8%), cardiovascular, renal and metabolic diseases (24.4%), respiratory and autoimmune diseases (14.6%), and other (21.2%; inflammatory diseases, neurological diseases, gastrointestinal and infectious diseases); - collaboration revenue (5.8%). Net sales are distributed geographically as follows: the United Kingdom (8.8%), Europe (21.6%), the United States (40.3%), Americas (5.9%) and Africa/Asia/Australia (23.4%).

Employees

94,300

Sector

Pharmaceuticals

Calendar

06-18 - J.P. Morgan European Healthcare Forum

More about the company